Interferon-alpha and -beta in kidney inflammation (Q37710960)

22 August 2017

1 reference

title

Interferon-alpha and -beta in kidney inflammation (English)

1 reference

22 August 2017

0 references

Hans-Joachim Anders

1

1 reference

22 August 2017

Julia Lichtnekert

series ordinal

2

1 reference

22 August 2017

Ramanjaneyulu Allam

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

17 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

77

1 reference

22 August 2017

10

1 reference

22 August 2017

848-854

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.71

22 August 2017

0 references

cites work

Interferons at age 50: past, current and future impact on biomedicine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Viral nephropathies: core curriculum 2008

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Viruses and kidney disease: beyond HIV.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Mechanisms of type-I- and type-II-interferon-mediated signalling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Interferons alpha and beta as immune regulators--a new look

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Type I interferons (alpha/beta) in immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

IRF family of transcription factors as regulators of host defense

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Type 1 interferons and the virus-host relationship: a lesson in détente .

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Innate immunity to virus infection.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

The role of differential expression of human interferon--a genes in antiviral immunity.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Innate pathogen recognition in the kidney: toll-like receptors, NOD-like receptors, and RIG-like helicases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: Implications for viral infection-associated glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Double-stranded RNA activates type I interferon secretion in glomerular endothelial cells via retinoic acid-inducible gene (RIG)-1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Viral RNA and DNA trigger common antiviral responses in mesangial cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Upregulation of MHC class II, interferon-alpha and interferon-gamma receptor protein expression in HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Renal disease in children with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Antiviral immune responses: triggers of or triggered by autoimmunity?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Toll-like receptor-7 modulates immune complex glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Type I IFN protects against murine lupus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Deficiency of the type I interferon receptor protects mice from experimental lupus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

A compass that points to lupus: genetic studies on type I interferon pathway.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Type I interferon and lupus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

The clinicopathological implications of endothelial tubuloreticular inclusions found in glomeruli having histopathology of idiopathic membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Pseudoviral immunity - a novel concept for lupus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB × NZW mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

G-rich DNA suppresses systemic lupus.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Interferon-beta reduces proteinuria in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Viral 5'-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.71

7 January 2021

Identifiers

DOI

10.1038/KI.2010.71

1 reference

22 August 2017

1 reference